Lv41
540 积分 2023-02-02 加入
Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
13天前
已完结
BW-00112 targeting ANGPTL3 results in prolonged reductions in plasma triglycerides, LDL-C, and remnant-C in human subjects
30天前
已完结
Real-world safety profile of eculizumab: an analysis of FDA adverse event reporting system and systematic review of case reports
1个月前
已完结
Efficacy and safety of ervogastat alone and in combination with clesacostat in patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis and F2–F3 fibrosis (MIRNA): results from a phase 2, randomised, double-blind, double-dummy study
1个月前
已完结
Can targeting de novo lipogenesis improve liver health?
1个月前
已完结
Current Clinical Trials for Treating Elevated Lipoprotein(a)
2个月前
已完结
Linker Design for The Antibody Drug Conjugates: A Comprehensive Review
2个月前
已完结
Efficacy and safety of ervogastat alone and in combination with clesacostat in patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis and F2–F3 fibrosis (MIRNA): results from a phase 2, randomised, double-blind, double-dummy study
2个月前
已完结
Synthesis and Evaluation of Cleavable Thiazolidine-Modified Nucleotides for DNA Sequencing
2个月前
已关闭
Fitusiran in haemophilia: a breakthrough drug with many unknowns
3个月前
已完结
皖公网安备34019202002308
